What is Ipamorelin?
Ipamorelin is a selective growth hormone secretagogue (GHS) and pentapeptide that stimulates growth hormone release through the ghrelin/GHS receptor (GHS-R1a). First developed in the late 1990s, ipamorelin is distinguished from other growth hormone-releasing peptides by its high selectivity for GH release without significantly affecting cortisol, prolactin, or ACTH levels.
The peptide consists of five amino acids (Aib-His-D-2Nal-D-Phe-Lys-NH2) and has a molecular weight of approximately 711.85 Da. Its compact structure and favorable selectivity profile have made it one of the most widely studied GHRPs in research settings.
Mechanism of Action
Ipamorelin acts primarily through the GHS-R1a receptor, the same receptor targeted by the endogenous hormone ghrelin. However, unlike ghrelin, ipamorelin demonstrates remarkable selectivity in its downstream effects.
GH Release: Upon binding to GHS-R1a on anterior pituitary somatotrophs, ipamorelin triggers GH release through a mechanism distinct from but complementary to GHRH stimulation. The GHS-R1a activates phospholipase C, increases intracellular calcium, and promotes GH exocytosis.
Selective Signaling: What sets ipamorelin apart from earlier GHRPs (such as GHRP-6 and GHRP-2) is its minimal effect on cortisol and prolactin secretion. Research has shown that even at high doses, ipamorelin produces negligible increases in these hormones, indicating a uniquely selective activation of GH-specific pathways.
Synergy with GHRH: Research has demonstrated synergistic effects when ipamorelin is combined with GHRH analogs like CJC-1295. The two peptides work through complementary pathways — GHRH via cAMP/PKA and ipamorelin via calcium/PKC — producing amplified GH release.
Key Research Applications
Growth Hormone Research
Ipamorelin is widely used in research studying GH secretion dynamics, including pulse amplitude, pulse frequency, and the relationship between GHS-R1a activation and somatotroph function. Its selectivity allows researchers to study GH effects in isolation without confounding hormonal changes.
Bone Density Research
Preclinical studies have demonstrated that ipamorelin promotes bone formation by increasing osteoblast activity and stimulating the GH/IGF-1 axis. Research in ovariectomized rat models has shown increased bone mineral content and improved bone strength parameters.
Body Composition Research
Studies have investigated ipamorelin’s effects on lean mass, fat mass, and overall body composition. The peptide’s ability to stimulate GH without cortisol elevation makes it particularly valuable for studying GH-mediated changes in body composition without catabolic interference.
Gastrointestinal Research
Research has explored ipamorelin’s effects on gastrointestinal motility, demonstrating prokinetic properties that may be mediated through both central GHS-R1a activation and peripheral ghrelin-like effects on enteric neurons.
Structure and Properties
- Molecular Formula: C38H49N9O5
- Molecular Weight: ~711.85 Da
- Amino Acid Count: 5 (pentapeptide)
- Sequence: Aib-His-D-2Nal-D-Phe-Lys-NH2
- Storage: Lyophilized at -20°C; reconstituted at 2-8°C
- Solubility: Soluble in sterile water and bacteriostatic water
- Purity: Research-grade typically ?98% by HPLC
Ipamorelin vs Other GHRPs
Compared to GHRP-6 and GHRP-2, ipamorelin offers superior selectivity. GHRP-6 is known to significantly stimulate appetite (via ghrelin receptor activation in the hypothalamus) and elevate cortisol, while GHRP-2 moderately increases prolactin and cortisol. Ipamorelin’s clean pharmacological profile makes it the preferred GHRP for research requiring isolated GH stimulation.
Handling and Storage
Store lyophilized ipamorelin at -20°C for optimal stability. Reconstitute with bacteriostatic water using standard aseptic technique. Reconstituted solutions remain stable at 2-8°C for up to 28 days. The peptide is relatively stable but should be protected from excessive heat and light.
Related Peptides
- CJC-1295 No DAC – GHRH analog often studied alongside ipamorelin
- Tesamorelin – GHRH analog for GH axis research
- AOD 9604 – GH fragment peptide
Conclusion
Ipamorelin’s exceptional selectivity for growth hormone release — without significant effects on cortisol, prolactin, or ACTH — has established it as the gold standard GHRP in research settings. Its clean pharmacological profile, synergistic potential with GHRH analogs, and diverse research applications in bone, body composition, and GI studies make it an indispensable tool for growth hormone researchers.
All products are sold strictly for research purposes only. Not for human consumption.